BlackRock’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$19.4M Sell
3,102,524
-437,424
-12% -$2.74M ﹤0.01% 3004
2025
Q1
$20.7M Sell
3,539,948
-11,509
-0.3% -$67.4K ﹤0.01% 2887
2024
Q4
$29.2M Buy
3,551,457
+391,043
+12% +$3.21M ﹤0.01% 2766
2024
Q3
$28.2M Buy
3,160,414
+155,052
+5% +$1.38M ﹤0.01% 2775
2024
Q2
$22.7M Buy
3,005,362
+560,521
+23% +$4.24M ﹤0.01% 2863
2024
Q1
$19.2M Buy
2,444,841
+346,096
+16% +$2.72M ﹤0.01% 2961
2023
Q4
$18.6M Buy
2,098,745
+234,719
+13% +$2.08M ﹤0.01% 2992
2023
Q3
$16.7M Sell
1,864,026
-8,106
-0.4% -$72.7K ﹤0.01% 2997
2023
Q2
$23.1M Buy
1,872,132
+541,032
+41% +$6.68M ﹤0.01% 2881
2023
Q1
$12.4M Buy
1,331,100
+277,973
+26% +$2.58M ﹤0.01% 3134
2022
Q4
$11.1M Buy
1,053,127
+39,672
+4% +$417K ﹤0.01% 3288
2022
Q3
$18.4M Buy
1,013,455
+126,732
+14% +$2.3M ﹤0.01% 3033
2022
Q2
$12.6M Buy
886,723
+611,696
+222% +$8.67M ﹤0.01% 3315
2022
Q1
$6.05M Buy
275,027
+36,244
+15% +$797K ﹤0.01% 3781
2021
Q4
$4.06M Buy
+238,783
New +$4.06M ﹤0.01% 4018